These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 3667376)
1. 5-Fluorouracil infusions and fractionated doses of radiation: studies with a murine squamous cell carcinoma. Weinberg MJ; Rauth AM Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1691-9. PubMed ID: 3667376 [TBL] [Abstract][Full Text] [Related]
2. Growth delay in a murine squamous cell tumor after local radiation and concurrent infusional 5-fluorouracil treatment. Weinberg MJ; Lapointe TA; Rauth AM Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1449-52. PubMed ID: 3759572 [TBL] [Abstract][Full Text] [Related]
3. Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours. Shibamoto Y; Murata R; Miyauchi S; Hirohashi M; Takagi T; Sasai K; Shibata T; Oya N; Takahashi M Br J Cancer; 1996 Dec; 74(11):1709-13. PubMed ID: 8956782 [TBL] [Abstract][Full Text] [Related]
4. Radiation enhancement by 9-aminocamptothecin: the effect of fractionation and timing of administration. Kirichenko AV; Rich TA Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):659-64. PubMed ID: 10348297 [TBL] [Abstract][Full Text] [Related]
5. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo. Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin. Kirichenko AV; Rich TA; Newman RA; Travis EL Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine. Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum, and tumor. Zaghloul MS; Dorie MJ; Kallman RF Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):417-25. PubMed ID: 8514539 [TBL] [Abstract][Full Text] [Related]
9. Radioenhancement by cisplatin with accelerated fractionated radiotherapy in a human tumour xenograft. Joschko MA; Webster LK; Bishop JF; Groves J; Yuen K; Olver IN; Narayan KN; Ball DL Cancer Chemother Pharmacol; 1997; 40(6):534-9. PubMed ID: 9332470 [TBL] [Abstract][Full Text] [Related]
10. Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus. Münch S; Pigorsch SU; Feith M; Slotta-Huspenina J; Weichert W; Friess H; Combs SE; Habermehl D Radiat Oncol; 2017 Nov; 12(1):182. PubMed ID: 29157271 [TBL] [Abstract][Full Text] [Related]
11. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Keane TJ; Cummings BJ; O'Sullivan B; Payne D; Rawlinson E; MacKenzie R; Danjoux C; Hodson I Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):613-8. PubMed ID: 8454478 [TBL] [Abstract][Full Text] [Related]
12. Variations of the hypoxic fraction in the SCC VII tumors after single dose and during fractionated radiation therapy: assessment without anesthesia or physical restraint of mice. Kitakabu Y; Shibamoto Y; Sasai K; Ono K; Abe M Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):709-14. PubMed ID: 2004947 [TBL] [Abstract][Full Text] [Related]
13. Concomitant 5-fluorouracil infusion, mitomycin C and radical radiation therapy in esophageal squamous cell carcinoma. Chan A; Wong A; Arthur K Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):59-65. PubMed ID: 2492271 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous tumor ablation: microencapsulated echo-guided interstitial chemotherapy combined with cryosurgery increases necrosis in prostate cancer. Le Pivert PJ; Morrison DR; Haddad RS; Renard M; Aller A; Titus K; Doulat J Technol Cancer Res Treat; 2009 Jun; 8(3):207-16. PubMed ID: 19445538 [TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of a novel antitumor prodrug, 1-(2'-oxopropyl)-5-fluorouracil (OFU001), which releases 5-fluorouracil upon hypoxic irradiation. Shibamoto Y; Zhou L; Hatta H; Mori M; Nishimoto SI Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):407-13. PubMed ID: 11173134 [TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer. Kohno N; Kitahara S; Tamura E; Tanabe T Oncology; 2002; 63(3):226-31. PubMed ID: 12381901 [TBL] [Abstract][Full Text] [Related]
17. Tumor growth and tumor radiosensitivity in mice given myeloprotective doses of fibroblast growth factors. Ding I; Huang K; Snyder ML; Cook J; Zhang L; Wersto N; Okunieff P J Natl Cancer Inst; 1996 Oct; 88(19):1399-404. PubMed ID: 8827018 [TBL] [Abstract][Full Text] [Related]
18. Combination of radiation therapy and intracranial bleomycin in the 9L rat brain tumor model. Kimler BF; Martin DF; Evans RG; Morantz RA; Vats TS Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1115-21. PubMed ID: 1693363 [TBL] [Abstract][Full Text] [Related]
19. Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systems. Kallman RF; Rapacchietta D; Zaghloul MS Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):227-32. PubMed ID: 1991683 [TBL] [Abstract][Full Text] [Related]
20. Schedule-dependent therapeutic gain from the combination of fractionated irradiation and cis-diamminedichloroplatinum (II) in C3H/Km mouse model systems. Kanazawa H; Rapacchietta D; Kallman RF Cancer Res; 1988 Jun; 48(11):3158-64. PubMed ID: 2966671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]